Patients with increase in serum creatinine more than 33% above baseline on 2 consecutive visits and/or serum creatinine above ULN, with and without concomitant cyclosporine use
| Cyclosporine use . | n (%) . | Two values > ULN,* no. (%) . | Two consecutive values > 33%,* no. (%) . | Two consecutive values > 33% and > ULN,* no. (%) . |
|---|---|---|---|---|
| No cyclosporine | 95 (82) | 8 (8.4) | 34 (35.8) | 19 (20.0) |
| Concomitant cyclosporine | 21 (18) | 3 (14.3) | 3 (14.3) | 10 (47.6)† |
| Total | 116 (100) | 11 (9.5) | 37 (31.9) | 29 (25.0) |
| Cyclosporine use . | n (%) . | Two values > ULN,* no. (%) . | Two consecutive values > 33%,* no. (%) . | Two consecutive values > 33% and > ULN,* no. (%) . |
|---|---|---|---|---|
| No cyclosporine | 95 (82) | 8 (8.4) | 34 (35.8) | 19 (20.0) |
| Concomitant cyclosporine | 21 (18) | 3 (14.3) | 3 (14.3) | 10 (47.6)† |
| Total | 116 (100) | 11 (9.5) | 37 (31.9) | 29 (25.0) |